Quetiapine granules
Patent 6599897 Issued on July 29, 2003. Estimated Expiration Date: 
March 21, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 21, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPharmaceutical compositions using thiazepine Patent #: 5948437 InventorAssigneeApplicationNo. 088804 filed on 03/21/2002US Classes:514/211.13, Nitrogen bonded directly to ring carbon of the seven-membered hetero ring424/499Contains proteins or derivative or polysaccharides or derivativeExaminersPrimary: Henley, III, RaymondAttorney, Agent or FirmForeign Patent References
International ClassesA61K 031/553A61K 009/50 Foreign Application Priority Data1999-09-21 GBAbstractGranule formulations of quetiapine and pharmaceutically acceptable salts thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as psychotic disease conditions including schizophrenia.Other References
| |
